期刊文献+

2型糖尿病及代谢综合征与非酒精性脂肪肝相关因素分析 被引量:4

The analysis of nonalcoholic fatty liver and its correlation factors in type 2 diabetes mellitus and metabolic syndrome
原文传递
导出
摘要 目的了解非酒精性脂肪肝(NAFLD)与2型糖尿病及代谢综合征的关系。方法收集137例代谢综合征患者,151例2型糖尿病患者,98例健康体检者。测血糖、血脂,测量身高及体重,计算体质指数(BMI)。受试者均行肝脏超声检查。结果健康对照组、2型糖尿病组、代谢综合征组NAFLD患病率分别为17%、36%、68%,差异有显著性(P<0.05)。脂肪肝组较非脂肪肝组血糖、血压、BMI、甘油三脂(TG)、低密度脂蛋白胆固醇(LDL-C)更高,高密度脂蛋白胆固醇(HDL-C)更低,差异有显著性(P<0.05)。Logistic回归分析显示NAFLD与BMI、FBG、DBP、TG相关。结论NAFLD与2型糖尿病及代谢综合征密切相关。 Objieetive To study the relationship of NAFLD with type 2 diabetes and metabolic syndrome. Methods 137patients with metabolic syndrome,151 type2 diabetes and 98 normal control subjects were enrolled. The levels of blood glucose, pressure and lipid measured. Body mass index(BMI) was calculated according to the height and weight of the patients. All the subjects were performed hepatic Bmode ultrasonography. Results The prevalence of NAFLD in normal control subjects, type 2 diabetes and patients with metabolic syndrome was 17% ,36% and 68% respectively. The difference of prevalence between those groups was significant( P 〈 0. 05). The levels of blood glucose, pressure ,TG, LDL, BMI in patients with NAFLD were higher than those in patients without NAFLD. While the HDL levels in patients with NAFLD were lower in patients without NAFLD. The difference between patients with and without NAFLD was significant(P 〈0. 05 ). Logistic regression revealed that NAFLD was correlated with BMI, FBG,DBP and TG. Conelution NAFLD correlated closed with type2 diabetes and metabolic syndrome.
出处 《临床内科杂志》 CAS 2007年第10期682-684,共3页 Journal of Clinical Internal Medicine
关键词 2型糖尿病 代谢综合征 非酒精性脂肪肝 Type 2 diabetes Metabolic Syndrome Nonalcoholic fatty liver
  • 相关文献

参考文献5

二级参考文献14

  • 1李继强.脂肪肝的影像学诊断[J].辽宁医学杂志,2004,18(2):65-67. 被引量:7
  • 2Marchesini G,Brizi M,Bianchi G,et al.Nonalcoholic fatty liver disease:A feature of the metabolic syndrome.Diabetes,2001,50:1844-1850.
  • 3Vozarova B,Stefan N,Lindsay RS,et al.High alanine aminotransferase is associated with decrease hepatic insulin sensitivity and predicts the development of type 2 diabetes.Diabetes,2002,51:1189-1895.
  • 4Nakanishi N,Suzuki K,Tatara K.Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middleaged Japanese men.Diabetes Care,2004,27:1427-1432.
  • 5Nannipieri M,Gonzales C,Baldi S,et al.Liver enzymes,the metabolic syndrome and incident diabetes:The mexico city diabetes study.Diabetes Care,2005,28:1757-1762.
  • 6Hanley AJ,Williams K,Festa A,et al.Elevations in markers of liver injury and risk of type 2 diabetes the insulin resistance atherosclerosis study.Diabetes,2004,53:2623-2632.
  • 7http://digestive.niddk.nih.gov/ddiseases/pubs/nash/
  • 8Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 9Willner IR,Waters B,Paul SR,et al.Ninety patients with nonalcoholic steatohepatitis:insulin resistance,familial tendency,and severity of disease.Am J Gastroenterol,2001,96:2957-2961.
  • 10Marchesini G,Bugiansi E,Forlani G,et al.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome.Hepatology,2003,37:917-923.

共引文献4571

同被引文献26

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部